PPIA and lung carcinoma: Notably, the expression levels of both PPIA and BSG were increased at advanced cancer stages in liver hepatocellular carcinoma and lung adenocarcinoma, indicating that the overexpression of CypA/CD147 may be associated with the poor prognosis of patients with liver or lung cancer.